Full-length sequencing data of recombinant adeno-associated virus (rAAV) vectors is critical to the development of effective gene therapy products. Highly accurate HiFi sequencing has the unique advantage of capturing and sequencing entire AAV genomes so gene therapy researchers can characterize potential therapeutic products with confidence and precision.
In this on-demand bioinformatics webinar, PacBio scientist Dr. Elizabeth Tseng demonstrates how to generate and analyze full-length AAV sequencing data to profile packaged genomes as a single intact molecule, measure impurities, and ensure vectors contain the intended design. Watch the recording to also hear industry leaders at Homology Medicines and AavantiBio discuss how, when, and where they use the PacBio full-length AAV sequencing platform to improve their overall gene therapy research program and comprehensively assess their designs.
Register to watch recording
Ted Kalbfleisch, Ph.D., Associate Professor, University of Kentucky
Mitchell Feldmann, Ph.D., Postdoctoral Fellow, University of California, Davis.